Annual Total Expenses
$172.87 M
+$57.71 M+50.12%
31 December 2023
Summary:
Akero Therapeutics annual total expenses is currently $172.87 million, with the most recent change of +$57.71 million (+50.12%) on 31 December 2023. During the last 3 years, it has risen by +$92.72 million (+115.67%). AKRO annual total expenses is now at all-time high.AKRO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$81.70 M
+$15.96 M+24.28%
30 September 2024
Summary:
Akero Therapeutics quarterly total expenses is currently $81.70 million, with the most recent change of +$15.96 million (+24.28%) on 30 September 2024. Over the past year, it has increased by +$35.09 million (+75.27%). AKRO quarterly total expenses is now at all-time high.AKRO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +50.1% | +75.3% |
3 y3 years | +115.7% | +235.5% |
5 y5 years | +1154.7% | +401.0% |
AKRO Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +115.7% | at high | +235.5% |
5 y | 5 years | at high | +1154.7% | at high | +560.0% |
alltime | all time | at high | +1154.7% | at high | >+9999.0% |
Akero Therapeutics Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $81.70 M(+24.3%) |
June 2024 | - | $65.74 M(+9.7%) |
Mar 2024 | - | $59.95 M(-3.1%) |
Dec 2023 | $172.87 M(+50.1%) | $61.87 M(+32.7%) |
Sept 2023 | - | $46.62 M(+30.8%) |
June 2023 | - | $35.63 M(+23.9%) |
Mar 2023 | - | $28.75 M(+13.1%) |
Dec 2022 | $115.16 M(+14.1%) | $25.42 M(-29.6%) |
Sept 2022 | - | $36.09 M(+30.8%) |
June 2022 | - | $27.59 M(+5.9%) |
Mar 2022 | - | $26.05 M(-19.7%) |
Dec 2021 | $100.89 M | $32.44 M(+33.2%) |
Sept 2021 | - | $24.35 M(-15.9%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $28.97 M(+91.5%) |
Mar 2021 | - | $15.13 M(-49.2%) |
Dec 2020 | $80.15 M(+75.6%) | $29.78 M(+38.3%) |
Sept 2020 | - | $21.54 M(+30.9%) |
June 2020 | - | $16.45 M(+32.9%) |
Mar 2020 | - | $12.38 M(-23.7%) |
Dec 2019 | $45.65 M(+231.3%) | $16.22 M(-0.5%) |
Sept 2019 | - | $16.31 M(+114.3%) |
June 2019 | - | $7.61 M(+38.0%) |
Mar 2019 | - | $5.51 M(+85.7%) |
Dec 2018 | $13.78 M | $2.97 M(+71.9%) |
Sept 2018 | - | $1.73 M(-80.1%) |
June 2018 | - | $8.66 M(+1957.5%) |
Mar 2018 | - | $421.00 K |
FAQ
- What is Akero Therapeutics annual total expenses?
- What is the all time high annual total expenses for Akero Therapeutics?
- What is Akero Therapeutics annual total expenses year-on-year change?
- What is Akero Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Akero Therapeutics?
- What is Akero Therapeutics quarterly total expenses year-on-year change?
What is Akero Therapeutics annual total expenses?
The current annual total expenses of AKRO is $172.87 M
What is the all time high annual total expenses for Akero Therapeutics?
Akero Therapeutics all-time high annual total expenses is $172.87 M
What is Akero Therapeutics annual total expenses year-on-year change?
Over the past year, AKRO annual total expenses has changed by +$57.71 M (+50.12%)
What is Akero Therapeutics quarterly total expenses?
The current quarterly total expenses of AKRO is $81.70 M
What is the all time high quarterly total expenses for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total expenses is $81.70 M
What is Akero Therapeutics quarterly total expenses year-on-year change?
Over the past year, AKRO quarterly total expenses has changed by +$35.09 M (+75.27%)